Return to Search
EN
Three-dimensional (3D) echocardiography offers advanced visualization and assessment capabilities crucial for diagnosing and planning various cardiac interventions.
For the mitral valve, 3D echocardiography provides a detailed, surgery-like view of the anterior and posterior leaflets and their scallops. This allows for precise identification of problematic areas before surgery, enabling surgeons to develop a clear procedural strategy. Furthermore, it accurately assesses patient suitability for transcatheter mitral valve repair (MitraClip) procedures, which are performed via a groin approach. The technology's utility extends to evaluating the tricuspid and pulmonary valves as well.
In cases of congenital heart defects (e.g., septal defects), 2D echocardiography may not fully capture the complex shape of the defect, potentially leading to an unsuitable closure device selection. 3D echocardiography, however, accurately visualizes and measures these defects, including their long and short axes, ensuring the selection of the most appropriate closing device for transcatheter implantation.
Another significant application is in the transcatheter aortic valve implantation (TAVI) procedure. For patients with impaired renal function, contrast-enhanced computed tomography (CT), typically used for pre-procedural planning, may be contraindicated. In such scenarios, 3D echocardiography offers a valuable alternative for detailed assessment and measurement. While this specific application requires specialized expertise and training beyond routine cardiology practice, its clinical benefits are substantial. It allows patients with renal insufficiency to undergo TAVI planning without exposure to contrast agents. Accurate 3D echo measurements in these cases are critical for optimal valve selection and minimizing peri-procedural complications.
How is Stargardt's Disease Treated?
For the mitral valve, 3D echocardiography provides a detailed, surgery-like view of the anterior and posterior leaflets and their scallops. This allows for precise identification of problematic areas before surgery, enabling surgeons to develop a clear procedural strategy. Furthermore, it accurately assesses patient suitability for transcatheter mitral valve repair (MitraClip) procedures, which are performed via a groin approach. The technology's utility extends to evaluating the tricuspid and pulmonary valves as well.
In cases of congenital heart defects (e.g., septal defects), 2D echocardiography may not fully capture the complex shape of the defect, potentially leading to an unsuitable closure device selection. 3D echocardiography, however, accurately visualizes and measures these defects, including their long and short axes, ensuring the selection of the most appropriate closing device for transcatheter implantation.
Another significant application is in the transcatheter aortic valve implantation (TAVI) procedure. For patients with impaired renal function, contrast-enhanced computed tomography (CT), typically used for pre-procedural planning, may be contraindicated. In such scenarios, 3D echocardiography offers a valuable alternative for detailed assessment and measurement. While this specific application requires specialized expertise and training beyond routine cardiology practice, its clinical benefits are substantial. It allows patients with renal insufficiency to undergo TAVI planning without exposure to contrast agents. Accurate 3D echo measurements in these cases are critical for optimal valve selection and minimizing peri-procedural complications.